← Back to Search

Survivorship Care Coordination for Prostate Cancer

N/A

Waitlist Available

Led By Ronald C Chen

Research Sponsored by NRG Oncology

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

The ADT must be planned for at least 4 months and must include luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist

The participant must be able to complete required questionnaires in English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 24 months after completion of radiation therapy (rt)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether increasing the coordination of care between the cancer care team and the primary care team improves care and outcomes for prostate cancer survivors.

Who is the study for?

This trial is for prostate cancer survivors who are undergoing radiation and androgen deprivation therapy. They must be able to fill out questionnaires in English, have a primary care provider or cardiologist, and consent to the study. Practices need IRB approval, complete specific training, and follow certain protocols. Patients already on ADT for no more than 120 days may join.

What is being tested?

The trial tests if increasing survivorship care planning can improve outcomes for prostate cancer survivors on therapy that raises risks of diabetes and heart issues. It compares standard care with an increased dose of coordinated survivorship care between oncologists and primary caregivers.

What are the potential side effects?

Since this trial focuses on survivorship care planning rather than a medical intervention, there are no direct side effects from treatments like drugs or surgery being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for hormone therapy for my cancer for at least 4 months.

Select...

I can complete questionnaires in English.

Select...

I have prostate cancer and will be treated with radiation and hormone therapy aiming for a cure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 24 months after completion of radiation therapy (rt)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 24 months after completion of radiation therapy (rt)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 24 months after completion of radiation therapy (rt) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of patients who saw a primary care provider (PCP) or cardiologist and had their cholesterol checked

Proportion of patients who saw a primary care provider (PCP) or cardiologist and had their fasting blood glucose checked

Secondary study objectives

Eligible screened patients with a PCP or cardiologist

High health literacy levels

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Enhanced Survivorship Care Plan (SCP)Experimental Treatment3 Interventions

Practices review a treatment plan with patient and send it to the PCP at the beginning of RT. Practices also review a SCP with patients and send it to the PCP during the last week of RT.

Group II: Standard Survivorship Care Plan (SCP)Active Control2 Interventions

Practices review a SCP with patients and send it to the PCP during the last week of RT.

0 / 3Eligibility criteria met